SBC Medical Group Holdings Acquires Controlling Stake in Waqoo, Inc.

SBC Medical Group Acquires MB career lounge (JUN CLINIC)

July 17, 2025

Healthcare Services

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) acquired MB career lounge, Co., Ltd., a Japan-based provider of management support, consulting, training and HR solutions for aesthetic medical institutions, in a share purchase transaction closed on July 17, 2025. The deal brings JUN CLINIC's multi-location aesthetic dermatology and plastic surgery operations into SBC Medical's clinic network to accelerate regional expansion, diversify services and strengthen revenue stability.

Healthcare Holding Switzerland Acquires Schaublin Medica SA

April 15, 2025

Medical Devices

Healthcare Holding Switzerland AG has acquired 100% of Schaublin Medica SA from its founders as part of a succession plan. Schaublin Medica, based in Plan-les-Ouates, specializes in distribution of vascular grafts, endoprostheses, stents and drug‑coated balloon catheters to hospitals across Switzerland and will join Healthcare Holding's medical-technology platform to expand product and service offerings.

WiQo (via WiQo US) Acquires Love Beauty Pro & Medical to Expand U.S. Presence

March 25, 2024

Healthcare Services

Italian aesthetic-medicine company WiQo (through its newly formed WiQo US, Inc.), backed by healthcare private equity firm ARCHIMED, has acquired Boston-based Love Beauty Pro & Medical, the long-time U.S. distributor and training partner for WiQo's PRX Derm Perfexion. The deal brings distribution, sales and clinical training capabilities in-house to accelerate WiQo's U.S. expansion and deepen local provider relationships.

Asahi Kasei Medical Acquires Bionova Scientific

April 14, 2022

Biotechnology

Asahi Kasei Medical agreed to wholly acquire Bionova Scientific, a Fremont, California-based biopharmaceutical CDMO that provides process development and GMP-compliant manufacturing services for next-generation antibody drugs. The acquisition, executed through a U.S. subsidiary, expands Asahi Kasei Medical's bioprocess and CDMO capabilities to better serve biologics developers and accelerate growth of its bioprocess business; closing is subject to regulatory clearances.

SWCC and Development Bank of Japan Acquire TOTOKU Inc. from Carlyle

February 21, 2025

Manufacturing

Global investment firm Carlyle has agreed to sell TOTOKU Inc., a Japanese manufacturer of specialty wires and electronic devices, to SWCC Corporation and the Development Bank of Japan. The transaction (a Carlyle divestiture) is subject to customary approvals and was announced February 21, 2025 with closing expected by the end of March 2025.

Shin Nippon Biomedical Laboratories Acquires Satsuma Pharmaceuticals

April 16, 2023

Biotechnology

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) has entered into a definitive agreement to acquire all outstanding shares of Satsuma Pharmaceuticals for $0.91 per share in cash plus a non-tradeable contingent value right (CVR) of up to $5.77 per share tied to future monetization of STS101. The transaction gives SNBL ownership of Satsuma's investigational intranasal migraine product STS101 and associated delivery technology, and is supported by Satsuma’s board as maximizing value for stockholders.